TABLE 1.
Clinical data for ovarian cancer TMA
| Patient | Histologic subtype | Stage | Grade | DFS (mo) | OS (mo) | Patient status | Ascites |
|---|---|---|---|---|---|---|---|
| 1 | Serous | IV | 3 | 17.5 | 20.7 | Deceased | No |
| 2 | Serous | III | 2 | 13.7 | 32.3 | Deceased | No |
| 3 | Squamous | III | 3 | 9.5 | - | - | Yes |
| 4 | Transitional cell | III | 3 | 26.6 | 162.3 | Alive | Yes |
| 5 | Serous | III | 3 | 8.3 | 12 | Deceased | No |
| 6 | High grade serous | III | 3 | 53.3 | 63.5 | Deceased | No |
| 7 | Serous and endometrioid | III | 2 | 39.8 | 43.1 | Deceased | No |
| 8 | Serous | III | 2 | 14.3 | - | - | Yes |
| 9 | Serous | IV | 3 | 16.5 | 18.8 | Deceased | Yes |
| 10 | Serous | IV | 3 | 12.7 | 43.7 | Deceased | Yes |
| 11 | Serous | III | 3 | 10.5 | 14.5 | Deceased | No |
| 12 | Serous | III | 3 | 14 | 31.5 | Deceased | Yes |
| 13 | Serous | III | 3 | 34 | - | - | Yes |
| 14 | Serous | IV | 3 | 12.2 | 31.6 | Deceased | Yes |
| 15 | Serous | III | 3 | 34.8 | 64.4 | Deceased | Yes |
| 16 | Serous | III | 3 | 24.3 | 146.7 | Deceased | Yes |
| 17 | Serous | IV | 3 | 12.8 | 15.8 | Deceased | Yes |
| 18 | Serous | IV | 3 | 9.5 | 12.5 | Deceased | Yes |
| 19 | Serous | III | 3 | 16.5 | 56.7 | Deceased | No |
| 20 | Serous | IV | 3 | 12 | 13 | Deceased | Yes |
| 21 | Serous | IV | 2 | 38.1 | 50 | Deceased | Yes |
| 22 | Endometroid | III | 3 | 45.1 | 79.6 | Deceased | Yes |
| 23 | Serous | IV | 3 | 11.4 | - | - | Yes |
| 24 | Serous | IV | 1 | 21.9 | 100.7 | Deceased | Yes |
| 25 | Serous | III | 3 | 23.1 | 53.8 | Deceased | No |
| 26 | Endometrioid and clear cell | IV | 3 | 5.3 | 16.9 | Deceased | No |
DFS, interval between the date of diagnosis and the date of recurrence; OS, interval between the date of surgery to last follow-up or death.